Pre-market Analysis

1)Nifty closed at 11308.40 down 0.12% and banknifty closed at 22264.00 up 0.17%.

2)Global markets closed positive yesterday. Today being expiry,will be very volatile day.

3)Today, US and Europe futures are trading in mixed and asian markets opened mixed and sgx nifty future is trading at 11331 up 0.18%.

4) We may open gap up of around 40-50 pts and follow global futures as the day progresses,good support now stands at 11k mark with resistance at 11500.

5)Support and resistance for Nifty and Banknifty  for intraday.




6)Nifty option pain is at 11300 and banknifty option pain is at 22000.

7)Nifty may trade between 11200 and 11500 and banknifty may trade between 22000 and 22500 for this week.this are very strong support and resistances as per oi chain.

8)Results today 


9)Stocks in news.

Britannia
Company allots commercial paper of Rs 300 cr, the board will also meet on 17th Aug to consider Further fund raising through commercial paper

Adani Power
A New national Record ~ a 660 MW supercritical unit (U#7) at 4620 MW Mundra Power Thermal Plant has created a new national record by running continuously for 411 days.

Apollo Hospital
NCLT approves Scheme of Arrangement between Apollo Hospitals Enterprise Limited and Apollo Pharmacies Limited and their respective shareholders

Dr Reddy’s 
Gets US FDA Nod For Ear Infection Drugs Ciprofloxacin & Dexamethasone

Aurobindo Pharma
Gets US FDA Nod For Low Blood Pressure Drug Midodrine Hydrochloride

10)Results

ABB Power
Q1FY21, YoY
Sales down 41.7% to Rs 633.2 v/s Rs 1086.3 cr
EBITDA Down 70.9% to Rs 34.2 v/s Rs 117.5 cr
EBITDA margins down to 5.4% v/s 10.8%
Profit down 82% to Rs 10.9 v/s Rs 60.7 cr

Balaji Amines
Q1FY21, YoY
Sales flat at 222.9 v/s 223 cr
EBITDA Up 41.9% to Rs 53.2 v/s Rs 37.5 cr
EBITDA margins Up to 23.9% v/s 16.8%
Profit Up 70.8% to Rs 31.6 v/s Rs 18.5 cr

Aurobindo Pharma Q1, YoY
Net Profit Up 22.8% at 780.7 Cr Vs 635.7 Cr
Revenue Up 8.8% at 5,924.8 Cr Vs 5,444.6 Cr
EBITDA Up 9.7% at 1,257.4 Cr Vs 1,146.4 Cr 
EBITDA Margin at 21.2% Vs 21.1%

Ashok Leyland Q1, YoY
Net Loss at 388.8 Cr Vs Profit Of 230.2 Cr 
Revenue Down 88.5% At 651 Cr Vs 5,683.1 Cr 
EBITDA Loss at 333.1 Cr Vs EBITDA Profit Of 536.2 Cr

Aarti Ind Q1. Cons, YoY
Net Profit Down 41.4% at 83.2 Cr Vs 141.9 Cr 
Revenue Down 9.7% at 937.3 Cr Vs 1,038.4 Cr
EBITDA Down 27.2% at 182 Cr Vs 250.1 Cr
EBITDA Margin at 19.4% Vs 24.1%


11)F&O BAN
New in Ban: AUROPHARMA
Still in Ban: BATAINDIA, CANBK, CENTURYTEX, GLENMARK, IBULHSGFIN, IDEA, MUTHOOTFIN, SAIL, VEDL

12)Happy Trading

13)Follow our telegram channel 'Optionstraders' for calls on equity and options.

Comments

Post a Comment

Popular posts from this blog

CAMS IPO, Bumper Listing ???

Image
About the Company 1. Computer Age Management Services (CAMS) Ltd is a technology-driven financial infrastructure and service provider.  2. It is India's largest registrar and transfer agent of mutual funds.  3. As per the Crisil Nov 2019 report, it has a 69.4% mutual fund aggregate market share. Business Areas - CAMS currently provides technology-based services including dividend processing, transaction origination interface, payment, transaction execution, dividend processing, intermediary empanelment, report generation, investor interface, settlement and reconciliation, compliance-related services, and brokerage computation. - The company provides services in the area of electronic payment collections services business, insurance services business, alternative investment funds services business, banking, and non- banking services business, KYC registration agency business, and software solutions business. CAMS has a wide network comprising 25 states, 278 service centers, and...
Read more

Equitas SFB IPO : Apply or Avoid???

Image
About The Company Equitas Small Finance Bank Ltd. (ESFB) is one of the largest SFB in India in terms of number of banking outlets Second largest SFB in India in terms of assets under management and total deposits in Fiscal 2019 Diversified Portfolio and  reduce its dependence on micro-finance business as compared to other micro-finance companies that have converted to SFBs. ESFB offers a range of banking products and services to customers with a focus on serving the financially un-served and under-served customer segments in India ESFB's distribution channels comprised 856 Banking Outlets and 322 ATMs across 17 states and union territories in India Business Areas The companies main bushiness comes from majorly following three areas : Small business loans which compromises of 41% of its business. Micro-Finance which  compromises of  23 % of its business. Vehicle loans compromise approximately 25% of the business Competitive Strengths A customer-centric organ...
Read more

CHEMCON IPO : Apply or Not ????

Image
  About the Company 1. Incorporated in 1988, Chemcon Speciality Chemicals Ltd is a manufacturer of specialized chemical products i.e. HMDS and CMIC 2. Chemcon Chemicals is a leading manufacturer of Pharmaceutical chemicals and generates maximum revenue from this particular segment Business Expertise - Oilfield chemicals (Calcium Bromide, Sodium Bromide, and Zinc Bromide) - Pharma intermediates, Silanes, and chemicals contract manufacturing work - It exports products to global markets covering the US, Germany, Italy, South Korea, Japan, the United Arab Emirates, Serbia, Russia, Spain, Thailand and Malaysia - Hetero Labs Limited, Laurus Labs Ltd, Aurobindo Pharma Ltd, Lantech Pharmaceuticals Ltd, Macleods Pharma Ltd are the key customers of its Pharma chemical business - Shree Radha Overseas, Universal Drilling Fluids, Water Systems Speciality are some of the clients of its oilfield chemicals segment. - KamalKumar Rajendra Aggarwal, Navdeep Naresh Goyal, and Shubharangana Goyal are t...
Read more